Independent origin of multiple foci of prostatic intraepithelial neoplasia: Comparison with matched foci of prostate carcinoma

Cancer

Volumn 83, Issue 9, 1998, Pages 1995-2002

  Bostwick, David G ^a   Shan, Ailin ^a   Qian, Junqi ^a   Darson, Micheal ^a   Maihle, Nita J ^b   Jenkins, Robert B ^a   Cheng, Liang ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Allelic imbalance; Field effect; Molecular biology; Prostate; Prostate neoplasms; Prostatic intraepithelial neoplasia

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CARCINOMA IN SITU; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CARCINOMA;

AGED; ALLELES; CARCINOMA; GENETIC HETEROGENEITY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS;

EID: 0032212356     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981101)83:9<1995::AID-CNCR16>3.0.CO;2-2     Document Type: Article

References (37)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-29.
2. McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 1986;7:64-71.
3. Bostwick DG. High grade prostatic intraepithelial neoplasia: the most likely precursor of prostate cancer. Cancer 1995;75:1823-36.
4. Bostwick DG, Pacelli A, Lopez-Beltran A. Molecular biology of prostatic intraepithelial neoplasia. Prostate 1996;29:117-34.
5. Qian J, Wollan P, Bostwick DG. The extent and multicentricity of high grade intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. Hum Pathol 1997;28:143-8.
6. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, et al. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 1995;55:2959-62.
7. Sakr WA, Macoska JA, Benson PD, Grignon DJ, Wolman SR, Pontes JE, et al. Allelic loss in metastatic, multisampled prostate cancer. Cancer Res 1994;54:3273-9.
8. Qian J, Bostwick DG, Takahashi S, Borell TJ, Herath JF, Lieber MM, et al. Chromosomal anomlies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 1995;55:5408-14.
9. Cunningham JM, Shan A, Wick MJ, McDonnell SK, Schaid DJ, Tester DJ, et al. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res 1996;56:4475-82.
10. Jenkins RB, Qian J, Lieber MM, Bostwick DG. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res 1997;57:524-31.
11. Macoska JA, Micale MA, Sakr WA, Benson PD, Wolman SR. Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis. Genes Chromosome Cancer 1993;8:88-97.
12. Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, et al. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization. Cancer Res 1994;54:3574-9.
13. Latil A, Baron JC, Cussenot O, Fournier G, Soussi T, Boccon-Gibod L, et al. Genetic alterations in localized prostate cancer: identification of a common region of deletion on chromosome arm 18q. Genes Chromosome Cancer 1994;11:119-25.
14. Vocke CD, Pozzatti RO, Bostwick DG, Florence CH, Jennings SB, Strup SE, et al. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res 1996;56:2411-6.
15. Trapman J, Sleddens HFBM, van der Weiden MM, Dinjens WNM, Konig JJ, Schroder FH, et al. Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 1994;54:6061-4.
16. Carter BS, Ewing CM, Ward WAS, Treiger BF, Aalders TW, Schalken JA, et al. Allelic loss of chromosome 16q and 8q in human prostate cancer. Proc Natl Acad Sci USA 1990;87:8751-5.
17. Zenklusen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ. Loss of heterozygosity in human primary prostate carcinoma: a possible tumor suppressor gene at 7q31.1. Cancer Res 1994;54:6370-3.
18. Ittmann MM. Loss of heterozygosity on chromosome 10 and 17 in clinically localized prostate carcinoma. Prostate 1996;28:275-81.
19. Ittmann MM, Wieczorek R. Alterations of the retinoblastoma gene in clinically localized, stage B prostate adenocarcinoma. Hum Pathol 1996;27:28-34.
20. Cooney KA, Wetzel JC, Merajver SD, Macoska JA, Singleton TP, Wojno KJ. Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res 1996;56:1142-5.
21. Gao X, Zacharek A, Salkowski A, Grignon DJ, Sakr W, Porter AT, et al. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 1995;55:1002-5.
22. Cheng L, Song S, Pretlow TG, Abdul-Karim FW, Kung H-J, Tsai M, et al. Evidence of independent origin of multiple tumors from prostate cancer patients. J Natl Cancer Inst 1998;90:233-7.
23. Cher ML, Ito T, Weidner N, Carroll PR, Jensen RH. Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J Urol 1995;153:249-54.
24. Alers CA, Krijtenburg PJ, Vissers KJ, Bosman FT, van der Kwast TH, Dekken H. Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Genes Chromosome Cancer 1995;12:241-50.
25. Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstrahl E, Larson-Keller J, et al. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 1994;54:3998-4002.
26. Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, von Eschenbach AC, et al. Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosome Cancer 1994;9:19-27.
27. Zenklusen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ. Allelic imbalance in human primary prostate carcinoma: a possible tumor suppressor gene at 7q31.1. Cancer Res 1994;54:6370-3.
28. Brown JA, Alcaraz A, Takahashi S, Persons DL, Lieber MM, Jenkins RB. Chromosomal aneusomies detected by fluorescence in situ hybridization analysis in clinically localized prostate carcinoma. J Urol 1994;152:1157-62.
29. Dahiva R, McCarville J, Hu W, Lee C, Chui RM, Kaur G, Deng G. Chromosome 3p24-26 and 3p22-12 loss in human prostatic adenocarcinoma. Int J Cancer 1997;71:20-5.
30. Latil A, Cussenot O, Fournier G, Driouch K, Liderean R. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. Cancer Res 1997;57:1058-62.
31. Latil A, Fournier G, Cussenot O, Liderean R. Differential chromosome allelic imbalance in the progression of human prostate cancer. J Urol 1996;156:2079-83.
32. Cooney KA, Wetzel JC, Consolino CM, Wojno KJ. Identification and characterization of proximal 6q deletions in prostate cancer. Cancer Res 1996;56:4150-3.
33. Humphrey PA, Vollmer RT. Intraglandular tumor extent and prognosis in prostatic carcinoma. Hum Pathol 1990;21:799-804.
34. Greene DR, Egawa S, Neerhut G, Flanagan W, Wheeler TM, Scardino PT. The distribution of residual cancer in radical prostaectomy specimens in stage A prostate cancer. J Urol 1991;145:324-9.
35. Greene DR, Wheeler TM, Egawa S, Dunn JK, Scardino PT. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol 1991;146:1069-76.
36. Konishi N, Hiasa Y, Matsuda H, Tao M, Tsuzuki T, Hayashi I, et al. Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma. Am J Pathol 1995;147:1112-22.
37. Greene DR, Rogers E, Wessels EC, Wheeler TM, Taylor SR, Santucci RA, et al. Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features. J Urol 1994;151:1301-7.